- Home
- HOLO vs LVTX Comparison
HOLO vs LVTX Comparison
Compare HOLO & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOLO
- LVTX
- Stock Information
- Founded
- HOLO 2018
- LVTX 2016
- Country
- HOLO China
- LVTX Netherlands
- Employees
- HOLO N/A
- LVTX N/A
- Industry
- HOLO Computer Software: Programming Data Processing
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- HOLO Technology
- LVTX Health Care
- Exchange
- HOLO Nasdaq
- LVTX Nasdaq
- Market Cap
- HOLO 34.9M
- LVTX 33.1M
- IPO Year
- HOLO N/A
- LVTX 2021
- Fundamental
- Price
- HOLO $4.67
- LVTX $1.32
- Analyst Decision
- HOLO
- LVTX Hold
- Analyst Count
- HOLO 0
- LVTX 3
- Target Price
- HOLO N/A
- LVTX $1.75
- AVG Volume (30 Days)
- HOLO 7.1M
- LVTX 42.7K
- Earning Date
- HOLO 01-01-0001
- LVTX 05-14-2025
- Dividend Yield
- HOLO N/A
- LVTX N/A
- EPS Growth
- HOLO N/A
- LVTX N/A
- EPS
- HOLO N/A
- LVTX N/A
- Revenue
- HOLO $39,771,750.00
- LVTX $4,990,000.00
- Revenue This Year
- HOLO N/A
- LVTX N/A
- Revenue Next Year
- HOLO N/A
- LVTX N/A
- P/E Ratio
- HOLO N/A
- LVTX N/A
- Revenue Growth
- HOLO 42.62
- LVTX N/A
- 52 Week Low
- HOLO $4.63
- LVTX $0.85
- 52 Week High
- HOLO $1,472.00
- LVTX $2.52
- Technical
- Relative Strength Index (RSI)
- HOLO 35.42
- LVTX 55.48
- Support Level
- HOLO $5.06
- LVTX $1.18
- Resistance Level
- HOLO $7.63
- LVTX $1.34
- Average True Range (ATR)
- HOLO 1.54
- LVTX 0.07
- MACD
- HOLO 0.47
- LVTX 0.00
- Stochastic Oscillator
- HOLO 0.56
- LVTX 87.50
About HOLO MicroCloud Hologram Inc.
MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library. Geographically company is operating in single segment, China.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.